862468-65-3

Basic information

• Product Name: 3-benzyl-1-propyl-3,7-dihydropurine-2,6-dione
• Synonyms: 3-benzyl-1-propyl-3,7-dihydropurine-2,6-dione
• CAS NO: 862468-65-3
• Molecular Weight: 284.318
• Mol File: 862468-65-3.mol

Chemical Properties

• CAS DataBase Reference: 3-benzyl-1-propyl-3,7-dihydropurine-2,6-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 3-benzyl-1-propyl-3,7-dihydropurine-2,6-dione(862468-65-3)
• EPA Substance Registry System: 3-benzyl-1-propyl-3,7-dihydropurine-2,6-dione(862468-65-3)

Safety Data

• Hazardous Substances Data: 862468-65-3(Hazardous Substances Data)

Upstream product

• 64-18-6 formic acid 
• 200557-55-7 5,6-diamino-1-benzyl-3-propylpyrimidine-2,4(1H,3H)-dione 
• 862468-60-8 6-amino-1-benzyl-5-nitroso-3-propylpyrimidine-2,4(1H,3H)-dione 

Downstream Products

• 862468-79-9 3-benzyl-7-(2-biphenyl-4-yl-2-oxoethyl)-8-bromo-1-propyl-3,7-dihydropurine-2,6-dione 
• 862468-86-8 3-benzyl-8-bromo-7-(2-cyclohexyl-2-oxoethyl)-1-propyl-3,7-dihydropurine-2,6-dione 
• 862468-80-2 3-benzyl-8-bromo-7-[2-(4-fluorophenyl)-2-oxo-ethyl]-1-propyl-3,7-dihydropurine-2,6-dione 
• 862468-78-8 3-benzyl-8-bromo-7-(2-(4-methoxyphenyl)-2-oxo-ethyl)-1-propyl-3,7-dihydropurine-2,6-dione 
• 862468-67-5 3-benzyl-8-bromo-7-(2-oxo-2-phenylethyl)-1-propyl-3,7-dihydropurine-2,6-dione 
• 862468-85-7 3-benzyl-8-bromo-7-(2-cyclopropyl-2-oxoethyl)-1-propyl-3,7-dihydropurine-2,6-dione 
• 862468-84-6 3-benzyl-8-bromo-7-(3,3-dimethyl-2-oxobutyl)-1-propyl-3,7-dihydropurine-2,6-dione 
• 862468-82-4 3-benzyl-8-bromo-7-(2-oxobutyl)-1-propyl-3,7-dihydropurine-2,6-dione 
• 862468-88-0 3-benzyl-8-bromo-7-(1-methyl-2-oxobutyl)-1-propyl-3,7-dihydropurine-2,6-dione 
• 862468-83-5 3-benzyl-8-bromo-7-(3-methyl-2-oxobutyl)-1-propyl-3,7-dihydropurine-2,6-dione 
• 862468-87-9 3-benzyl-8-bromo-7-(1-methyl-2-oxopropyl)-3,7-dihydropurine-2,6-dione 
• 862468-81-3 3-benzyl-8-bromo-7-(2-oxopropyl)-1-propyl-3,7-dihydropurine-2,6-dione 

Relevant articles and documents

Novel adenosine A3 receptor modulators

A class of novel antagonists for the adenosine A3 receptor are disclosed. These compounds are useful as therapeutic agents for a number of diseases and medical conditions that are mediated by the A3 receptor. The compounds of this in

New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A3 adenosine receptor antagonists

Compounds presenting an additional fused ring on the xanthine nucleus have been reported to exhibit antagonistic activity with various levels of affinity and selectivity toward the four adenosine receptors subtypes A1, A2A, A2B